WO2007073163A1 - Selection de biocatalyseurs de synthese chimique - Google Patents

Selection de biocatalyseurs de synthese chimique Download PDF

Info

Publication number
WO2007073163A1
WO2007073163A1 PCT/NL2006/000646 NL2006000646W WO2007073163A1 WO 2007073163 A1 WO2007073163 A1 WO 2007073163A1 NL 2006000646 W NL2006000646 W NL 2006000646W WO 2007073163 A1 WO2007073163 A1 WO 2007073163A1
Authority
WO
WIPO (PCT)
Prior art keywords
biocatalyst
product
host cell
candidate
gene
Prior art date
Application number
PCT/NL2006/000646
Other languages
English (en)
Inventor
Bernard Witholt
Jan Berthold Van Beilen
Stephan Johannes Hubertus Van Sint Fiet
Original Assignee
Eidgenössische Technische Hochschule Zürich
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eidgenössische Technische Hochschule Zürich filed Critical Eidgenössische Technische Hochschule Zürich
Priority to US12/158,335 priority Critical patent/US20090227470A1/en
Publication of WO2007073163A1 publication Critical patent/WO2007073163A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B30/00—Methods of screening libraries
    • C40B30/06—Methods of screening libraries by measuring effects on living organisms, tissues or cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1079—Screening libraries by altering the phenotype or phenotypic trait of the host
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1086—Preparation or screening of expression libraries, e.g. reporter assays
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B30/00—Methods of screening libraries
    • C40B30/08—Methods of screening libraries by measuring catalytic activity

Definitions

  • the invention relates to production of (bio)chemicals and more in particular to systems for the detection of biocatalysts capable of catalyzing the reaction from a substrate to a desired (bio)chemical product.
  • Biocatalyst technology as a part of chemical biotechnology, is increasingly important as a tool for chemical synthesis. Its application is driven by consumer demand for new products, by industrial attempts at reducing costs and increase profits, and by government regulatory pressures. Current applications of biocatalysts include the production of high fructose corn syrup, aspartame, semi-synthetic penicillins and novel cancer drugs. In fact it is expected that biocatalysis will revolutionize industrial chemistry in the next few decades, producing compounds from specialties to bulk chemicals. This is so because the potential pool of native and modified biocatalysts is enormous.
  • Biocatalytic enzymes play a pivotal role in organic synthesis processes.
  • An increasing number of industrial products, ranging from pharmaceutical intermediates to bulk chemicals, are manufactured with processes that involve one or more biocatalytic steps, foreshadowing the emergence of a significant biotechnology based chemical industry.
  • a key factor in this development is the availability of biocatalysts that enable good overall process efficiency and low production costs. This requires enzymes that show the necessary regio- and enantioselectivity, activity, and stability for desired bioconversions, under practical process conditions.
  • the present invention now relates to the use of an inducible expression system controlled by the presence in a host cell of a specific product the presence of which is dependent on the presence of a functional enzyme capable of catalyzing the reaction from at least one (generally extracellularly added) substrate to a desired specific product.
  • the present invention relates to a method of detecting among a population of candidate biocatalysts a biocatalyst capable of catalyzing a chemical conversion reaction from a substrate to a product, said method comprising the steps of: a) providing a host cell comprising:
  • At least one product-inducible expression system comprising nucleic acid encoding at least one detector gene operably linked to a regulatory element, wherein the expression of said detector gene is inducible by said product, and
  • biocatalyst expression system comprising nucleic acid encoding at least one candidate biocatalyst, wherein said at least one candidate biocatalyst is selected from said population of candidate biocatalysts; b) contacting said host cell with said substrate under conditions wherein said nucleic acid encoding at least one candidate biocatalyst is expressed in said host cell and wherein said substrate is allowed to contact said candidate biocatalyst, and wherein said substrate is converted into said product in case said candidate biocatalyst is capable of catalyzing said reaction, and c) detecting said host cell as one comprising a biocatalyst capable of catalyzing said chemical conversion reaction on the basis of the expression of said detector gene.
  • the present invention pertains to various embodiments of this aspect.
  • the product-inducible expression system and biocatalyst expression systems may be introduced into a host cell separately or simultaneously, or one system may be native for the host cell. In general, it will be easier to introduce the product-inducible expression system into a suitable host strain, thereby producing a detector strain.
  • libraries of biocatalyst expression systems may then be introduced into the detector strain.
  • a product-inducible expression system may be introduced into a population of similar organisms each of which contain one or more dissimilar genes that encode a biocatalyst that potentially has the desired bioconversion properties.
  • the referred population of organisms is herein said to comprise or represent a library of candidate biocatalysts.
  • the library may consist of variants of a gene which encodes a known or suspected desired biocatalyst. Variants of a gene may for instance be produced in the laboratory with one of several known techniques, such as site directed mutagenesis, directed evolution or DNA shuffling techniques. Alternatively, the dissimilar genes may constitute cloned nucleic acid fragments derived from one source organism (e.g. a shotgun cloned genome) or derived from many source organisms (e.g. a metagenome). Alternatively the library may consist of different known or unknown organisms, each of which naturally comprises one or more candidate biocatalysts and which organisms are modified by the introduction of the product-inducible expression system.
  • the invention relates to a method wherein step a) comprises the provision of a multitude of host cells that represents said population of candidate biocatalysts, wherein said multitude of host cells:
  • - is a library of cells of a single cell type wherein essentially each host cell comprises a different cloned nucleic acid fragment encoding at least one candidate biocatalyst, or
  • each host cell comprises a different candidate biocatalyst.
  • the condition under which said host cell is contacted with said substrate is such that it provides an inducer for activating the expression of said at least one biocatalyst expression system.
  • the step of detecting said host cell as a cell comprising a biocatalyst capable of catalyzing said chemical conversion reaction preferably comprises the survival of such cells under selective growth conditions. This means that the detection of cells that contain active biocatalysts is preferably based on the expression of a detector gene that enables the cells to survive under conditions that are lethal or growth inhibiting for cells that do not express the detector gene. Such conditions may for instance comprise a growth medium comprising an antibiotic compound for which the resistance is encoded by said detector gene.
  • the detection method allows the selection of at least one candidate biocatalyst from said population of candidate biocatalysts if the required product capable of inducing detector gene transcription is produced from said substrate.
  • the detection method may therefore additionally comprise the selection of a biocatalyst, which is essentially performed by selection of the host cell. It is therefore envisioned that the detection method of the present invention may comprise an additional step d) wherein said biocatalyst is provided by selecting and providing the host cell(s) detected in step c).
  • the present invention relates to a host cell suitable for use in a method of the invention as described above, said host cell comprising: a) at least one product-inducible expression system comprising nucleic acid encoding at least one detector gene operably linked to a regulatory element, wherein the expression of said detector gene is inducible by said product, and b) at least one biocatalyst expression system comprising nucleic acid encoding at least one candidate biocatalyst, wherein said at least one candidate biocatalyst is selected from said population of candidate biocatalysts.
  • the host cell is one cell out of multitude of host cells that represents said population of candidate biocatalysts, wherein said multitude of host cells:
  • - is a library of cells of a single cell type wherein essentially each host cell comprises a different cloned nucleic acid fragment encoding at least one candidate biocatalyst, or
  • the present invention provides a method of selecting among a population of candidate substrates a substrate capable of being converted into a product in a biocatalyst-catalyzed chemical conversion reaction, said method comprising the steps of: a) providing a host cell according to the present invention; b) subjecting said host cell to conditions wherein said detector gene allows for the detection of cells capable of forming said product, and c) selecting said substrate on the basis of the expression of said detector gene.
  • the present invention provides a method of producing a (bio)chemical compound wherein said compound is the product of a biocatalyst-catalyzed chemical conversion reaction for converting substrate into product, said method comprising the steps of: a) detecting and providing a biocatalyst by a method of the present invention; b) producing said biocatalyst by one of several possible transgenic methods in a production strain, or using the selected host cell as a production strain; c) providing a reaction mixture comprising said production strain and a substrate for the chemical conversion reaction catalyzed by said biocatalyst, and d) allowing said substrate to be converted by said biocatalyst thereby providing the (bio)chemical compound as the reaction product.
  • the host cell is a bacterial cell, a plant cell, an insect cell, a mammalian cell, or another animal cell, such as birds and reptile cells.
  • the detector gene i.e. gene to be activated or repressed by the interaction of said product with the regulatory gene, is a reporter gene, the expression of which causes the host cell to produce a detectable signal, such as a gene for a fluorogenic or chromogenic marker.
  • the detector gene is a selector gene, the expression of which permits host cells to grow under conditions where cells that do not express this same selector gene are not able to grow.
  • a suitable example of such a gene is a gene for a resistance marker.
  • the product-inducible expression of said detector gene is brought about by binding of said product to a regulatory protein and wherein said regulatory protein has the ability to bind to DNA and activate transcription from said at least one product-inducible expression system.
  • said regulatory element of said at least one product- inducible expression system is a binding site for said regulatory protein.
  • the biocatalyst expression system is activated by an externally provided inducer.
  • the at least one biocatalyst expression system comprises nucleic acid encoding at least two candidate biocatalysts each capable of catalyzing at least one reaction of a multi-step chemical conversion reaction.
  • the product of the reaction catalyzed by one of said at least two candidate biocatalysts is the substrate for the reaction catalyzed by another of said at least two candidate biocatalysts and/or the nucleic acid encoding said at least two candidate biocatalysts is comprised on separate expression systems for the separate candidate biocatalysts.
  • Figure 1 shows an illustrative example of the reporting and selection mechanisms used in aspects of the present invention in overview.
  • bacterial cells express a library of potential enzymes (Ei, E2, ...E n ), and substrate S is converted to desired product P in those cells that contain an enzyme capable of this conversion.
  • the regulatory protein and the detector gene are herein encoded on a detector plasmid (herein also referred to as the detector expression systems).
  • Figure 2 shows the reporter vector pVSF2-lacZ and selector vector pVSF2-tet r that carry lacZa and tetA respectively, fused to the salicylate promoter, which are examples of a reporter gene expression system and a selector gene expression system respectively.
  • the NahR mutant enables and regulates expression of the reporter and selector genes in the presence of product.
  • Figure 3 shows the effect of varying benzoate (a) and 2-hydroxybenzoate (b) concentrations on growth of DH10B-pVSF2-tet r . Under non-selective conditions DHlOB-pVSF2-tet r is able to grow in the absence of an inducer (o), whereas under selective* conditions an inducer is required for growth ( ⁇ ). Error bars indicate standard deviations. * note that the tetracycline concentrations for the benzoate and 2-hydroxybenzoate assays were 22.5 ⁇ g/ml and 25 ⁇ g/ml, respectively.
  • Figure 4 shows the effect of varying benzaldehyde (a)
  • 2-hydroxybenzaldehyde (b) concentrations on growth of cells containing an active enzyme Under non-selective conditions cells with (o) and without (•) active enzyme are able to grow. Growth under selective* conditions requires an active enzyme and an aldehyde substrate. Cells containing an active enzyme are able to grow upon addition of benzaldehyde or 2-hydroxybenzaldehyde ( ⁇ ), whereas cells lacking an active enzyme fail to grow in the presence of benzaldehyde or 2-hydroxybenzaldehyde ( ⁇ ). Error bars indicate standard deviations. * note that the tetracycline concentrations for the benzaldehyde and 2-hydroxybenzaldehyde assays were 22.5 ⁇ g/ml and 25 ⁇ g/ml, respectively.
  • Figure 5 shows the selection of biocatalytically active cells from a background of inactive cells.
  • Biocatalytically active cells that contain the active enzyme XyIC were mixed with inactive cells in a ratio of l:10 5 .
  • About 10 7 cells were plated and incubated on non-selective (left) and selective plates (right).
  • Ten randomly chosen colonies from the selective plate were tested for XyIC; all contained the plasmid.
  • the cloned material may be inserted into the chromosomal or genome DNA of a host cell or may reproduce extrachromosomally. "Cloning” is referred to as the process of inserting DNA encoding a gene of interest into a vector, then establishing it as a stable part of a cell line.
  • expression vector refers to a relatively small DNA molecule that is used to introduce and express a specific gene into a target cell. Once the expression vector is inside the cell, the protein that is encoded by the gene is produced by the cellular transcription and translation machinery. Generally, these expression vectors include regulatory elements operably linked to the nucleic acid of the encoding specific gene (i.e. the nucleic acid for the candidate biocatalyst and/or the detector gene). “Transcription” refers to the synthesis of RNA on a DNA or RNA template. “Translation” refers to the synthesis of protein on the mRNA template.
  • Nucleic acid is "operably linked" when it is placed into a functional relationship with another nucleic acid sequence.
  • a promoter or enhancer is operably linked to a coding sequence if it affects the transcription of the sequence; or a ribosome binding site is operably linked to a coding sequence if it is positioned so as to facilitate translation.
  • "operably linked” means that the DNA sequences being linked are contiguous, and, in the case of a secretory leader, contiguous and in reading frame. Enhancers do not have to be contiguous.
  • the general approach is to detect the presence of a cell-associated biocatalyst capable of catalyzing a desired reaction, by using a bacterial regulatory protein that recognizes the reaction product and relays this signal to one or more detector systems (based, for example, on a reporter gene expression system or on a selector gene expression system) (see Figure 1).
  • detector systems based, for example, on a reporter gene expression system or on a selector gene expression system
  • the system links growth to intracellular formation of, preferably non-metabolized, biocatalysis products, enabling detection of a biocatalyst based on selective growth of biocatalytically active cells in a background of inactive cells.
  • This basic concept was expanded to the present invention, which uses a host cell-associated and product-induced expression system, also termed the detector system herein, for indicating the presence of the sought-for biocatalyst.
  • the biocatalyst detection system as outlined herein may encompass a single host-cell system or it may encompass a system of multiple interacting cells. For instance, two cells may interact when they produce certain compounds wherein each cell carries out one step in a synthesis reaction. In such cases, the multi-step process of the present invention may be performed by two or more interacting cells wherein one utilizes the substrate as referred to herein and forms an intermediate compound which in turn functions as a substrate for another host cell that (also) comprises a biocatalyst for producing the required product. In this way intricate pathways for the formation of products may be formed.
  • said single steps in a synthesis reaction may be combined in single cells, resulting in newly developed biochemical pathways for the synthesis of desired end products.
  • Methods of the prior art for detecting biocatalysts generally allow for the possibility of selecting cells that are capable of producing an essential nutrient, i.e. a medium component that, if omitted from a medium, prevents cell growth unless said cells have enzyme(s) to produce this component from other metabolites or other medium components.
  • Such methods have been used for the identification of enzymes that produce an essential nutrient or growth medium component, such as prephenate (MacBeath et al, 1998; Gamper et al., 2000), pyruvate (Griffiths et al, 2004) or ammonia (Robertson et al, 2004).
  • biocatalysis product is not an essential nutrient, or is not a metabolite
  • the methods of the prior art cannot be applied since cells that have the biocatalyst cannot not be selected over cells that do not.
  • biocatalysts suitable for the synthesis of said industrial chemical products cannot be selected on that basis.
  • a biocatalyst for any biocatalytic chemical product may now be detected, selected and provided, as long as a chemosensor can be provided, i.e. in the form of a product- inducible expression system for a detector gene, that is capable if signalling the presence of the biocatalyst, via sensing of the product.
  • the product-inducible expression system may sense a single product or a specific (group of) chemical(s).
  • a preferred embodiment of the present invention relates to products which are not essential growth medium components, a most preferred embodiment relates to products which are not natural metabolites of the host cell.
  • the present invention uses a host cell-associated detector system to indicate the presence of the sought-for biocatalyst.
  • the detector system may be based on any kind of biochemical cascade that indicates the occurrence of a cell-associated event in a single host cell, or even a series of host cells. Many such biochemical cascades are known in the art.
  • the cell-associated event in the present case is the conversion of a substrate into a product by a biocatalyst and the resulting interaction of the product with an inducer of the detector system, the inducer for instance being a regulatory protein.
  • detector systems Two exemplary detector systems that constitute preferred embodiments are described in more detail herein below: a) the reporter gene expression system and b) the selector gene expression system, which may be used individually or in combination in aspects of the present invention. Other detector systems may also be envisaged.
  • the detector system may for instance also comprise a hybrid form of a reporter-selector system.
  • the product-inducible detector gene expression system may take any form possible. In principle, a large variety of systems is available to the person skilled in the art. The present invention was reduced to practice by providing a three- component signaling system comprising: 1) product; 2) product-inducible transcriptional regulator; and 3) transcription control element/promoter. As stated, other systems are within the scope of the present invention. A non-limiting list of alternative combinations for the three-component system is provided in Table 1 below.
  • the cell-associated detector system may in one preferred embodiment comprise a genetic expression system based on a reporter gene, in which case the detector system is based on the host-cell associated production of a detectable chemical substance, said substance generally being referred to as a marker.
  • a preferred reporter expression system encompasses spontaneous or stimulated light emission, for instance through the expression of a gene for a fluorogenic or chromogenic marker.
  • the purpose of the reporter gene is to allow detection, preferably visual detection, of cells that express the reporter gene either in colonies on a plate, or in other configurations of individual cells or microcolonies.
  • the reporter gene expression system may either be based on positive or negative signaling. For instance, in positive signaling, cells that contain the desired biocatalyst produce the detectable substance and are detected, and, vice versa, in negative signaling, cells that contain the desired biocatalyst do not produce the marker and may for instance be detected by elimination of marked cells. This principle will hold for many of the detector systems mentioned herein.
  • reporter genes may be used as reporter genes in the context of the present invention, such as genes that encode enzymes which directly or indirectly contribute to chromogenic or fluorogenic characteristics.
  • a preferred embodiment of a reporter gene is a gene for a fluorogenic or chromogenic marker and the reporter gene expression system is preferably based on positive signaling.
  • the reporter gene expression system used in aspects of the present invention suitably comprises a nucleic acid encoding at least one reporter gene. The system may comprise more than one such gene, but one reporter gene will generally suffice.
  • Suitable methods for detection are based on a detectable change in the phenotype of the host cell which can include, for example, a change in enzyme activity, the onset of expression of soluble molecules or cell-surface molecules, cell cycle interference, modification of cell metabolism, etc..
  • the detector expression system may encompass induction, stimulation, acceleration, inhibition, blockage, or in general interference with for instance: cell mobility, such as chemotaxis; - cell division, such as to block septation such that cells continue to divide without separating, thereby forming strand-like filaments or a system that blocks cell division to create maxi cells; cell metabolism, such as a system that accelerates metabolism by inducing a C-source utilization pathway that enables cells to outcompete other cells of the population; cell density, such as systems that produce intracellular low density biopolymers like medium-chain-lenth polyhydroxyalkanoates, which reduce the density of cells and make them float; cell surface molecules, such as a system expressing an antigen, antibody, binding protein, adhesin or other surface molecule causing cells to interact, coagulate, become attached to the growth vessel wall or a specific matrix material, sink to the bottom of the growth vessel or float to the top of the medium; product excretion, such as for instance selective excretion of biocatalyst, whereby
  • the cell-associated detector system may in another preferred embodiment comprise a genetic expression system based on a selector gene, in which case the detector system is based on growth selection of the host-cell.
  • the purpose of the selector gene is to allow the selection of one or more host cells that contain an active biocatalyst on the basis of the expression of said selector gene. This means that the host cell containing the biocatalyst may be selectively recovered by growth selection (i.e., by supporting the growth or preventing growth inhibition of cells that express the selector gene).
  • the expression of a selector gene permits host cells to grow under conditions where cells that do not express this same selector gene are not able to grow.
  • selector gene-based detector system may sometimes be preferred over the reporter gene-based detector system because of its relative ease with which cells that contain the desired biocatalyst can be enriched and purified.
  • the selector gene-based detector system used in aspects of the present invention suitably comprises a nucleic acid encoding at least one selector gene.
  • the system may comprise more than one such gene, but one selector gene will generally suffice.
  • selector genes known in the art are suitable for use in the present invention.
  • genes include, but are not limited to, genes for antibiotic resistance; genes that complement an auxotrophy in the host cell, or any other conditionally lethal or growth-inhibiting mutation; and other genes that allow growth under specific conditions that do not permit growth of host cells that do not contain or express these same genes.
  • Such conditions include, but are not limited to, the inability of host cells to utilize various possible C-sources, the presence in the growth medium of toxic chemicals, protein toxins, toxic metals, or growth conditions which include extremes of temperature, pH, ionic strength, that is, conditions outside of the normal ranges for each of these characteristics for the said host cells.
  • the product-inducible expression of the detector gene may be brought about by positive control (e.g. binding of the desired product — which acts as an inducer - to an activator protein) or by negative control (e.g., binding of the product — which in this example acts as a repressor - to a repressor protein), in which case, for instance, a property that prevents cell growth is removed, allowing growth of those cells who are able to produce a compound that causes repression.
  • positive control e.g. binding of the desired product — which acts as an inducer - to an activator protein
  • negative control e.g., binding of the product — which in this example acts as a repressor - to a repressor protein
  • a property that prevents cell growth is removed, allowing growth of those cells who are able to produce a compound that causes repression.
  • Suitable selection detector systems broadly include genes that allow discrimination between growth of host cells under specific conditions and a lack of growth of host cells in the absence of these specific conditions.
  • induction based regulatory systems induction is coupled to growth by introducing conditions that enable growth.
  • repression based regulatory systems repression is coupled to growth by removing specific conditions that block growth.
  • Said specific conditions include the inability of host cells to utilize various possible C-sources, the presence in the growth medium of toxic chemicals, protein toxins, toxic metals, or physical growth conditions of temperature, pH, ionic strength, radiation, pressure or other conditions, outside of the normal ranges for each of these characteristics for the said host cells.
  • Preferred selection detector systems include: - genes for antibiotic resistance;
  • the host cell population from which a desired host cell or cells are to be selected are grown in the presence of a suitable antibiotic, and the selector gene is a gene for resistance to said antibiotic, since this will result in the selective outgrowth and thus in the selective enrichment of the host cell or cells of interest.
  • the detector genes comprised in the detector expression systems are preferably operably linked to one or more regulatory elements.
  • the detector gene may be operably linked to an inducible promoter for initiation of its transcription.
  • the detector systems may comprise the nucleic acid encoding the detector gene as well as optional regulatory elements in the form of expression systems, which expression systems may in turn be in the form of an expression cassette, which comprises detector gene and regulatory elements in the form of a nucleic acid construct.
  • regulatory element refers to one or more DNA sequences necessary for the expression of an operably linked coding (gene) sequence in a particular host cell.
  • the control sequences that are suitable for prokaryotes include a promoter, optionally an operator sequence, and a ribosome binding site.
  • Eukaryotic cells are known to utilize promoters, polyadenylation signals, promoter-proximal elements, upstream activating sequences (UASs), and enhancers.
  • the regulatory elements may include, but are not limited to, promoter sequences, ribosomal binding sites, transcriptional start and stop sequences, translational start and stop sequences, and enhancer or activator sequences.
  • a “promoter” is a region of DNA involved in binding of RNA polymerase in order to initiate transcription. "Enhancers” can stimulate transcription from a promoter tens of thousands of base pairs away. “Promoter-proximal elements”, generally lose their influence when moved further from the promoter.
  • the regulatory elements will generally be appropriate to the host cell used to express the genes of interest; for example, transcriptional and translational regulatory nucleic acid sequences from Bacillus are preferably used to express genes in Bacillus.
  • the expression cassettes may be transferred to an appropriate host cell by using an expression vector.
  • suitable regulatory sequences include a promoter and transcriptional start and stop sequences.
  • Promoter sequences as used herein may encode either constitutive or inducible promoters unless expressly stated otherwise.
  • the promoters may be either naturally occurring promoters or hybrid promoters.
  • Hybrid promoters which combine elements of more than one promoter, are also known in the art, and are useful in the present invention.
  • the salicylate promoter as used for inducing transcription of the selector gene expression system in the Examples may for instance be used. The skilled person is capable of identifying other promoters suitable for obtaining adequate expression of the reporter or selector gene. Adequate expression may for instance be obtained by controlling the copy number of the vector on which the promoter and the selector gene are placed
  • promoters for activation of transcription
  • regulatory proteins may serve as "chemosensors" in relaying the presence of the product to the detector system as will now be described.
  • the expression of the genes in the detector system is inducible by the product. This may in principle be realized by any method available to the skilled person. One way of achieving this is described in detail below.
  • This exemplary procedure constitutes a mere preferred embodiment of the invention.
  • the product-inducible expression of the detector gene is brought about by binding of the product to a regulatory protein that I
  • regulatory proteins bind to “regulatory elements”. More precisely, “regulatory elements” are binding sites for “regulatory proteins”.
  • regulatory protein as used herein is synonymous with the terms “transcription factor”, “transcriptional regulator” or “transcriptional activator protein” which are proteins capable of binding to a regulatory element and as a result thereof either stimulate or repress transcription. Both stimulatory and repressive forms of regulatory proteins may be used in aspects of the present invention.
  • the regulatory element of the reporter or selector expression system is a binding site for a regulatory protein.
  • the regulatory protein is the preferred "chemosensor" for sensing the presence of the product.
  • the specific physical interaction between product and regulatory protein provides a very suitably mechanism for product-inducible activation of transcription of the detector expression system.
  • Very suitable regulatory proteins are transcriptional regulators, such as the transcriptional activator protein NahR from P. putida, a LysR-type transcriptional regulator. Even more suitable are mutants of such transcriptional regulator proteins with a broader "inducer range", Le. which recognize more products as possible inducers for transcription activation.
  • the regulatory protein is preferably encoded by a constitutively expressed gene, as it is convenient that the components of the product-inducible detector expression system are available at sufficient levels inside the host cell, so that the expression of the detector gene will start immediately upon first appearance of product. Nonetheless, the regulatory protein may be encoded by a an inducible gene, i.e. a gene which is under control of a chemical inducer or one or more of a set of environmental inducing conditions, such as temperature, pressure, ionic strength or cell crowding.
  • the amount of regulatory protein is adequate for ensuring the regulatory function, i.e. for ensuring that the system responds to a suitable range of product concentrations.
  • the expression of the regulatory protein may be brought about by providing the host cell with a suitable expression system. If needed, a system for the expression of the regulatory protein is preferably provided for on a vector already used for introducing an expression system in the host cell, although a separate vector may also be used for introducing the system for the expression of the regulatory protein in the host cell.
  • its encoding gene may be placed on i) the vector containing the detector gene(s) ⁇ ) the vector containing the biocatalyst library ⁇ i) a separate vector with solely this purpose, iv) a separate vector with other functions or purposes or, v) the chromosome of the host cell.
  • the regulatory protein used for sensing/transducing the presence of the product and its cognate promoter are most suitably used in as a pair, in which case the choice of the promoter may depend on the choice of the regulatory protein that recognizes the product (see also Table 1).
  • Promoters may initiate the transcription of any reporter or selector gene placed downstream from it.
  • a non-limiting list of suitable detector genes is provided in Table 2.
  • Either of the expression systems mentioned herein may suitably be provided in the form of a nucleic acid construct or expression cassette, which in turn may be comprised in a suitable vector for transfer to the host cell.
  • a suitable vector for transfer to the host cell may be provided in the form of a nucleic acid construct or expression cassette, which in turn may be comprised in a suitable vector for transfer to the host cell.
  • the expression systems are each provided in the form of separate plasmids
  • the vectors are hereinafter referred to in singular form (a/the vector), although it is intended that a plural form (the vectors) is also included by that term.
  • the expression vector may be either a self-replicating extrachromosomal vector or a vector which integrates into a host genome.
  • the expression vector may comprise additional elements.
  • the expression vector may have two replication systems, thus allowing it to be maintained in two organisms, for example in mammalian or insect cells for expression and in a prokaryotic host for cloning and amplification.
  • the expression vector may contain at least one sequence homologous to the host cell genome, and preferably two homologous sequences which flank the expression constructs.
  • the integrating vector may be directed to a specific locus in the host cell by selecting the appropriate homologous sequences for inclusion in the vector. Constructs for integrating vectors are well known in the art.
  • Either of the expression systems may include a marker gene (an additional marker gene in the case of the selector gene expression system, which system already comprises one selectable marker gene), operably linked to a regulatory element (such as a promoter), for the purpose of allowing the assessment of successful host cell transformation.
  • a marker gene an additional marker gene in the case of the selector gene expression system, which system already comprises one selectable marker gene
  • a regulatory element such as a promoter
  • Suitable marker genes for cell transformation purpose are non limiting and well known in the art.
  • a proper reference handbook for molecular cloning techniques and suitable expression vectors is Sambrook and Russell (2001). Minimum requirements are an origin of replication, a regulatable promoter and preferably multiple cloning sites. With PCR and DNA synthesis all desired elements can be introduced, combined, and arranged at will for optimal functionality of the vector.
  • biocatalyst is used herein to refer to a biochemical catalyst that activates or accelerates a chemical (conversion) reaction.
  • the biocatalyst will be an enzyme, however, it may also be a complex of enzymes, a combination of an enzyme and a co-factor, etc.
  • the term is intended to cover all forms of the compound(s), both in the form of a protein, possibly modified by covalent or non- covalent attachment of sugars, oligosaccharides, polysaccharides or fatty acids, lipids, steroids and other chemical substituents and compounds, in the form of a nucleic acid or in the form of a combination of several such compounds.
  • the true nature of the biocatalyst may first be established or assessed after its selection in ,a method of the present invention.
  • the population of candidate biocatalysts from which a biocatalyst is to be selected in a method of the present invention is very suitably provided in the form of a library of candidate nucleic acids.
  • Such nucleic acids may comprise much more information than that encoding the biocatalyst protein itself. However, this is of no consequence to its possible selection.
  • a "library” can be produced by digesting all DNA from a suitable source organism with a restriction enzyme and cloning the fragments into a vector, which will result in the production of many different recombinant vectors, each with a different fragment of DNA cloned into it.
  • the collection of many different recombinant vectors together forms the "library".
  • the library may be in the form wherein it is comprised in host cells or viruses, which facilitates its propagation or maintenance.
  • the library may be produced by any method available to the skilled person, for instance by shotgun cloning. "Shotgun cloning" is referred to as using the whole genome of an organism as the starting point for cloning.
  • DNA/RNA can be isolated from the environment, resulting in thousands of different genes which may have derived from many different organisms; such a collection of nucleic acid material is referred to as a metagenome.
  • specific libraries may be constructed that contain only genes expected to encode the desired biocatalysts, based for instance on DNA homologies, previous screening experiments, or commercially available libraries.
  • a library constructed by shotgun cloning techniques may contain from a few thousand (microorganisms) to hundreds of thousands (higher eukaryotes or microbial metagenomes) different recombinant plasmids while only one or a few harbor a sequence of interest. In order to reduce the size of libraries derived from eukaryotic organisms, it is sometimes advantageous to produce cDNA libraries.
  • cDNA library construction is well known to the skilled person.
  • Other library types include a library obtained by i) mutation (directed or random) of a single parent gene ii) recombination of several parent genes (such as libraries produced by gene shuffling) i ⁇ ) a combination thereof.
  • the "library” may be a library of genes or a library of organisms.
  • the host may already have the desired biocatalytic activity, and the aim of the invention is to develop an improved biocatalyst.
  • the population of candidate biocatalysts may for instance be provided in the form of a mixed population of potentially biocatalytically active bacterial cells, i.e. cells of different strains, for instance isolated from a soil or water sample, to which cells the reporter or selector systems are added, in order to select the best strain.
  • the library is a library of genes
  • these genes may be cloned from a source organism.
  • the library of genes may be generated through mutation of a single parent gene or by cutting genome(s) into fragments and inserting this into an expression vector.
  • the individual genes that together form the library or population of candidate biocatalysts may be encoded on chromosomal or episomal DNA (i.e. on a plasmid or other vector) They may be expressed constitutively; or they may be on an inducible expression vector, in which case they are expressed as a result of activation through one of various possible operably linked regulatory elements. In fact it is not limiting how and if the biocatalyst expression is induced. Expression may be constitutive, it might be under control of a native regulator, either known or not yet known, or it might be part of a library under control of a specifically designed induction system.
  • biocatalyst gene(s) is/are expressed, it is preferred that expression is sufficient to result in detectable (reporter or selector based) biocatalyst activity.
  • the sufficiency of the biocatalyst activity is ultimately determined by the sufficiency of product formation.
  • the activity of the candidate biocatalysts may range from non-detectable to detectable.
  • the biocatalyst expression system may in general have the same constitution as the detector expression system described in more detail above.
  • the biocatalyst gene will normally be operably linked to a regulatory element.
  • the expression of biocatalyst in the biocatalyst expression system may be constitutive or inducible by a suitable inducer. Either option may readily be realized by the skilled person through selection of a suitable promoter.
  • the biocatalyst expression system is activated by an externally provided inducer.
  • the expression of the biocatalyst nucleic acid may be under the control of the AIkS protein, a transcriptional regulator which, in the presence of alkanes, activates the expression of the PaIk promoter.
  • the biocatalyst expression system should also comprise the AIkS gene (including its own promoter).
  • Table 3 An exemplary list is provided in Table 3 below. Inducers for the various inducible expression systems used in aspects of the present invention may, but need not necessarily differ from one another.
  • the expression of the biocatalyst must be such that the level of production of the product will not result in the premature death of the host cell.
  • the expression of the biocatalyst may for instance be controllable, for which reason the biocatalyst expression is preferably inducible, or the host cell may be capable of excreting the product, or the product may be converted to a less harmful compound, or it may be degraded.
  • the concentration of the substrate in the medium the amount of product that can be formed is also lowered, and conditions are then sought that limit the amount of product made to a level that permits detection or selection of cells that contain the desired biocatalyst, but do not result in cell death.
  • the net effect of any of the foregoing or similar measures should be that a biocatalyst can be identified that does not result in damage to the cell that contains the biocatalyst.
  • At least one biocatalyst expression system may comprise the coding nucleic acid for at least two candidate biocatalysts, each capable of catalyzing at least one reaction of a multi-step chemical conversion reaction.
  • the product of the reaction catalyzed by one candidate biocatalyst is the substrate for the reaction catalyzed by another candidate biocatalyst.
  • nucleic acid encoding the various candidate biocatalysts may be provided in separate expression systems, each expression system facilitating the expression of a separate candidate biocatalysts. Also in this manner, multi-step chemical conversion reactions may be provided for.
  • the host organism may or may not itself harbour enzymes and optional co-factors for catalyzing an intermediate reaction from a multi- step reaction in which the candidate biocatalyst catalyzes the last step of converting the final intermediate compound into the desired product.
  • the intermediate compound may be a natural intermediate in the host cell, for the production of which the host cell likely has available an enzyme or a set of enzymes.
  • the candidate biocatalyst may produce an intermediate compound, which can be converted into a product by an enzyme naturally encoded for and expressed (i.e. available) in the host organism under the conditions provided.
  • the candidate biocatalyst need not necessarily catalyze the final reaction in a multi-step reaction process.
  • the enzyme system present in the host cell that contributes towards forming the inducer for activating transcription of the detector gene in such a multi-step system may be encoded on host cell chromosomal or episomal DNA, including possibly plasmid DNA that also encodes the product-inducible expression system itself.
  • the candidate biocatalyst as defined herein may also catalyze the critical reaction in a possible chain of reactions of a multi-step reaction process, which critical reaction is the sought after reaction that ultimately leads (possibly via additional reaction steps) to the production of the sought after product.
  • the chemical conversion reaction may be any chemical reaction which benefits from activation or acceleration by a biocatalyst.
  • Reaction types that can be catalyzed by the candidate biocatalyst include but are not limited to enzymes of each of the major enzyme classes and subclasses:
  • Isomerism is the property of compounds with identical molecular formulae but differing in the nature or the sequence of bonding of their atoms or in the arrangement of their atoms in space.
  • Chirality is the property of a compound being non-superimposable on its mirror image due to the presence of a carbon atom bonded to four nonidentical substituents (a chiral center).
  • the product may be R or S or a racemic mixture of enantiomers.
  • the product may be in the form of individual diastereomers or as a diastereomeric mixture, wherein the compound(s) may have cis, trans, Z or E configuration when a rotation hindering double bond is present.
  • reference handbooks on the subject e.g. Williams, 1999; Noyori, 1994.
  • the detector expression system may be in the form of a biocatalyst secretion system, wherein the nucleic acid that encodes the candidate biocatalyst is fused to a secretory leader sequence. Upon its secretion, the biocatalyst may then be isolated directly from the test medium. In all cases the biocatalysts may be isolated and purified if desired using conventional techniques, including but not limited to filtration, precipitation, crystallization, chromatography, and the like.
  • the biocatalysts may be characterized using conventional means, including methods to determine biocatalytic properties (kinetic data, substrate specificity and substrate range) and physicochemical properties such as solubility and stability data and spectral data.
  • the term "host cell” as used herein refers to the cell with which the detector system for indicating the presence of the sought-for biocatalyst is associated.
  • the host cell of the present invention may be any host cell capable of providing the cellular transcription and translation machinery required for expression of the population of candidate biocatalysts and of the necessary components of the detector systems.
  • One very advantageous host cell for this purpose is the host cell in which the vectors comprising the library of biocatalyst genes is maintained.
  • host cells that are better equipped for the expression of the phenotype brought about by the detector gene may also be used.
  • a suitable host cell that comprises a suitable product-inducible expression system for a detector gene
  • both detector expression systems and the biocatalyst expression system are introduced into a host cell separately. All these embodiments are envisioned in aspects of the invention.
  • the choice for the host cell may suitably be based on the compatibility of expression vectors with the host and the availability of suitable regulatory elements. Most important however, is the availability in a host cell line or compatibility with a host cell line of a product- inducible gene expression system wherein the product of interest activates or represses transcription of the detector gene .
  • the host cell may be a micro-organism, such as a prokaryotic microorganism or a eukaryotic micro-organism, a plant cell, or an animal cell line.
  • Suitable prokaryotes include both archaea and bacteria.
  • Suitable eukaryotic micro-organisms include yeast cells, fungi or protist cells.
  • Suitable animal cell lines are for instance insect cell lines or cells of birds, reptiles, and fish, but also mammalian (including human) cell lines may be used.
  • Preferred host cells are bacterial host cell lines because the bacterial metabolism provides for the simplest metabolic environment wherein the inducer function of the product is least likely to be disturbed.
  • the term "capable of facilitating or permitting access of said substrate to said biocatalyst” means that the host cell must be capable of enabling the substrate to access the sought for biocatalyst such that contact between substrate and biocatalyst can be made. This generally implies that the substrate must pass through the cell envelope or membrane system (a process generally referred to as “substrate uptake") to reach a biocatalyst that resides within the cytoplasm or other cell compartments. (Bacterial) cells can be modified to improve uptake of larger molecules. However, biocatalysts may also be located in plasma or cytoplasmic cell membranes or even outside these membranes in periplasmic or other extracytoplasmic spaces.
  • substrates may have access to biocatalysts without actually passing through cell membranes.
  • An exemplary category of detector proteins in the periplasmic space are the chemotactic receptors. These recognize a wide range of compounds, may be modified to recognize new compounds, and are known to transfer signals across the cytoplasmic membrane, switching on motility genes (or other selectable genes). Chemotaxis should be understood as being a possible detection method as referred to herein, as properly modified cells may "swim" towards the substrate in case they are capable of converting it to a product recognized by the chemotactic receptor.
  • the choice for a particular detector gene will require the provision of a corresponding test environment or selective growth environment.
  • an antibiotic resistance gene such as for instance the tetracycline resistance gene tetA
  • the provision in the growth medium of the antibiotic tetracycline is essential
  • a chromogenic gene such as for instance the lacZ gene
  • the provision in the growth medium of X-GaI is essential, in order to permit detection of the desired phenotype.
  • Test media for assaying the various detector gene expression systems are well known in the art and generally include pH buffers and a suitable aqueous saline base.
  • substrate refers to the reactant in the biocatalyst-catalyzed reaction, i.e. the chemical compound that interacts with the active site of the biocatalyst and is converted to a product, preferably (directly into) the desired product.
  • the host cell may comprise some sort of specialized or general uptake system for transporting the substrate across the cell membrane in order to take up the substrate.
  • this is not essential as simple diffusion of the substrate across the cell membrane into the intracellular environment is also envisioned, as is conversion in extracytoplasmic spaces or even in membranes as described above.
  • vectorial transport systems may for instance be present, where a single membrane located protein system carries out transmembrane transport while converting the substrate to a product. As a result, the substrate emerges in the cytoplasm in the form of product.
  • a cell will take up a given substrate depends on the availability or absence of specific or general uptake systems encoded by genes located on cellular chromosomes or on extrachromosomal DNA. Furthermore, substrate transport through cellular membranes also depends on the chemical properties of the substrate itself (e.g. hydrophobicity, ionic character) and the permeability of the host cell membrane. It should be understood that if the biocatalyst is produced in a certain cell compartment, it is essential that the substrate can be in direct physical contact with the biocatalyst so that conversion into the product can take place. In analogy, the product should be capable of inducing the activation of detector gene transcription, so that direct physical contact between the various essential compounds must be possible. The lack of or limited compartmentation of the prokaryote cell, also therefore makes such a cell very suitable as a host cell in aspects of the inventions.
  • the substrate in aspects of the invention is chosen such that it is the most likely candidate for being converted into the desired product.
  • benzaldehyde was chosen as a substrate for the production of benzoate.
  • the skilled person is capable of selecting a substrate such that it can be taken up by the cell and provides for a suitable candidate substrate for the sought after conversion reaction.
  • suitable substrates may be information relating to metabolic pathways and to information on the biosynthesis of compounds found in various biological organisms, such as microorganisms, animals and plants (see for instance the KEGG databases, such as KEGG Pathway, KEGG genes and KEGG Ligand at http://www.genome.ad.jp/kegg/kegg2.html).
  • Also of aid in selecting suitable substrates may be schemes for preparation of (organic) chemical compounds which are used in methods known to those skilled in the art following procedures set forth in handbook references such as Fieser and Fieser, 1991 or the series Organic Reactions (John Wiley & Sons, New York, (1942-), Volumes 1-40). Modifications to the conversion reaction may be made and will be suggested to one skilled in the art having referred to the disclosure contained in this application.
  • the substrates used in the sought after biocatalyst conversion reaction for preparing the product compound generally are either available from commercial suppliers, such as Aldrich Chemical Co., or may be prepared by methods known to the skilled person, including the procedures described herein.
  • the test substrate may suitably be provided in the form of a pool of candidate substrates for one or more possible given reactions, in order to assess the presence of a suitable substrate for the reaction, which substrate can be converted into one or more products detected by the sensing component of the product-inducible detector system.
  • a complete library of potential substrate compounds may be added to the test or growth medium, preferably in the form of defined groups, so that one or more suitable substrates can be detected and/or selected.
  • this method for finding a suitable substrate may optionally be performed simultaneously as part of a method for selecting a biocatalyst according to the present invention, so that parallel to a test series of candidate biocatalysts a series of candidate substrates is tested, for instance by testing multiple (groups of) substrates for each candidate biocatalyst.
  • the biocatalyst detection system as outlined herein may also consist of multiple interacting cells. For instance, two cell may interact when they produce certain compounds wherein each cell carries out one step in a synthesis reaction, the one utilizing the substrate as referred to herein and forming an intermediate compound which in turn functions as a substrate for the other cell that performs a subsequent bioconversion reaction. Intricate pathways for the formation of desired industrial products may thus be constructed. It should be understood that as the biocatalyst expression system may also comprise various conversion reactions from the substrate to the ultimate product that induces the product-inducible expression system with the detector gene, (i.e.
  • these multi-step bioconversions may be performed by two or more interacting host cells.
  • a chain of biocatalytic reactions may be constructed that can ultimately result in the advantageous production of sought-after chemicals. Therefore, the present invention in providing a method for detecting a biocatalyst, also provides a method for producing chemical compounds using the systems as disclosed herein.
  • a method for detecting a biocatalyst according to the invention may essentially be performed as follows:
  • a multitude of host cells is provided, each comprising an expression system for a candidate biocatalyst and each provided with a product-inducible selector expression system as described herein, in this case with a product-inducible antibiotic resistance gene.
  • the host cells are introduced in a growth medium, comprising essential growth nutrients, as well as a test substrate and an antibiotic compound at a level sufficient to inhibit the growth of cells not capable of expressing the antibiotic resistance gene.
  • the test substrate is a suitable substrate for the reaction which substrate can be converted into one or more products detected by the sensing component of the product-inducible reporter or selector system.
  • a library of potential substrate compounds may be added to the medium, preferably in the form of defined groups, so that one or more suitable substrates can be detected and/or selected.
  • the growth medium may further comprise one or more inducer compounds for initiating the expression of one or more biocatalysts inside the host cells in case their expression is inducible.
  • the induction of one or more biocatalyst expression systems need not be continuous, but may also be discontinuous to the extent that expression is needed.
  • the host cell is allowed to express the candidate biocatalyst and the substrate is allowed to contact the biocatalyst. Upon said contact a period of time is allowed to lapse that is sufficient for conversion of the substrate into product and induction of the selector expression system by the product in cells that express a suitable biocatalyst. Upon expression of the selector expression system, cells that express a suitable biocatalyst will start to overcome the antibiotic growth inhibition and grow, while growth of the remaining cells will remain inhibited by the antibiotic compound.
  • the composition of the growth medium is determined by the host cell requirements.
  • concentration of substrate molecules in the growth medium will generally range between 1 ⁇ M and IM. Suitable concentrations can easily be determined by the skilled person.
  • the reactions described herein preferably take place at atmospheric pressure over a temperature range from about 0 0 C to about 150 0 C, more preferably from about 5 0 C to about 70 0 C.
  • the methods involving the host cells will generally be performed at a host cell-specific temperature, which in the case of micro-organisms may be in the range of about 20 °C-37 0 C.
  • the host cell in aspects of the present invention recognizes the product chemical by using a specific chemosensor.
  • a suitable example of such a chemosensor is a regulatory protein.
  • these chemosensors Upon recognition or sensing of a given chemical, these chemosensors activate the transcription of a reporter or selector gene.
  • the presence of a specific product of a chemical conversion reaction activates downstream transcription from a promoter-region and subsequent translation of the functional mRNA into the gene product of the reporter or selector gene.
  • This general system is used herein to specifically sense a preselected biocatalysis product, and allows for the possibility of testing for the presence of biocatalysts that convert a substrate to the sensed product, for instance the conversion of the substrate benzaldehyde to the product benzoate by the biocatalyst benzaldehyde dehydrogenase.
  • FIG. 1 The selection system based on product-dependent activation of transcription of a detector gene by a regulatory protein as described here above is shown in figure 1, which essentially depicts an illustrative example of the present invention.
  • Still another aspect of the present invention is a method of selecting a substrate for a pre-selected and defined biocatalytic reaction.
  • a method of selecting a (bio)chemical compound as described above which method is essentially similar, provided that instead of working with a population of candidate biocatalysts, the method is performed with a population of candidate substrates and by using essentially a host cell comprising a single functional biocatalyst expression system or a set of such biocatalyst expression systems coupled to a product-inducible marker expression system, which host cell is contacted with candidate substrates.
  • testing compounds in pools has several advantages.
  • Yet another aspect of the present invention is a method of producing a (bio)chemical compound.
  • a method of producing a (bio)chemical compound comprises the selection of a biocatalyst by a method of the invention. Once the biocatalyst is selected, it may be isolated and optionally purified as described. Alternatively, the gene sequence can be unravelled so that the enzyme can be produced by transgenic methods well known in the art.
  • the host cell wherein the biocatalyst is produced at high levels is termed a production strain.
  • the production strain may produce the biocatalyst intracellularly or may secrete the protein, optionally as a fusion protein.
  • the protein can be isolated from the growth medium, optionally after removal of the cells. Additional processing, such as purification of the protein may be necessary.
  • the skilled person is well acquainted with the various techniques for protein purification aimed at providing functional enzyme.
  • the biocatalyst may be used in a method for the manufacture of the product, simply by allowing it to convert the substrate under suitable reaction conditions. Conversion generally will take place in a reaction mixture comprising the biocatalyst and one or more substrates and if needed, cofactors, for the biocatalytic conversion reaction, optionally in the presence of additional compounds, such as buffers, chelators, ions or reducing compounds supporting the proper conformational folding of the enzyme.
  • additional compounds such as buffers, chelators, ions or reducing compounds supporting the proper conformational folding of the enzyme.
  • the biotransformation of substrate into product can be performed by using permeabilized cells, resting cells, growing cells, or a combination of these as biocatalysts.
  • the biotransformation can be performed by using crude cell extracts as biocatalysts.
  • the biocatalysts can be immobilized on or in a water insoluble carrier or support system.
  • the biotransformation can be performed in aqueous medium. It can also be performed in multi-phasic media possibly comprising two or more of the following: a solid phase, an aqueous phase, an organic phase, or a gaseous phase.
  • reaction conditions generally depend on the temperature optimum of the enzymatic reaction. Upon recovery, the product, remaining substrates and cofactors may be further purified by methods known in the art.
  • the selector gene (the detector gene) is an antibiotic resistance gene, and thus, wherein the process is essentially based on selection for growth in the presence of an extracellularly added antibiotic.
  • the host is tailored to sense the production of benzoate or 2-hydroxybenzoate from their corresponding aldehydes with an appropriate dehydrogenase, XyIC from Pseudomonas putida.
  • XyIC dehydrogenase
  • the chemosensor system is expected to recognize these same compounds (benzoate or 2- hydroxybenzoate), as well as other compounds that happen to bind to the chemosensor in question, independently of the source of these compounds.
  • biocatalytic reactions that the host cell is capable of carrying out, or via various metabolic pathways consisting of multiple biocatalysts present in the host cell, all of these reactions and pathways based on biocatalysts that are encoded on chromosomal or episomal DNA present in the host cell, or additional DNA introduced into the host cells. Any or several of these biocatalytic activities may have been present in the host cells or may have been introduced into the host cells knowingly or inadvertently.
  • One frequently used approach is to examine host cells that contain a complete product sensing system before they are further modified by the introduction of DNA or RNA sequences that contain possible biocatalyst encoding genes, to confirm that the sensing system of the host cells fails to recognize any of the products that can be sensed by the sensing system.
  • Another frequently used approach is to examine the same host cells that contain a complete product sensing system before they are further modified by the introduction of DNA or RNA sequences that contain possible biocatalyst encoding genes, to confirm that the sensing system of the host cells fails to recognize any of the products that can be sensed by the sensing system when the substrate or substrates to be used in the identification and selection of desired biocatalysts are added to such cells.
  • test system modifications include the use of alternative host cells that are again used for the introduction of the sensing and detection or selection systems. Other modifications include altering the host cell to remove or reduce the effectiveness of genes that might encode biocatalysts that produce product that can be sensed by the sensing system of these host cells.
  • the medium may be provided with substances capable of degrading excreted product.
  • the net effect of these and other host cell or assay modifications is to reduce the response of the host cells in the absence of added substrates or added biocatalysts and preferably also added product, so that the effects of added substrates and added biocatalysts will be distinguishable from the effects of omitting substrates or biocatalysts, and so that production of product does not "leak through" to non- producing cells.
  • the formed benzoate or 2-hydroxybenzoate is sensed by a regulatory sensing protein.
  • a regulatory sensing protein This could be one of many proteins that bind small molecules, such as receptor proteins or antibodies.
  • a transcriptional regulatory protein is used that recognizes the product P, but not the substrate S, and then activates transcription of one of several possible detector genes (as illustrated in Figure 1).
  • the chemosensor controls the expression of one or more detector genes, so that the presence of an active benzaldehyde dehydrogenase can be reported or, in a selective environment, be used to select for growth of only those cells that are biocatalytically active.
  • the selection approach is illustrated here for benzaldehyde dehydrogenase cloned in an Escherichia coli host that was modified to recognize the presence of one or more desired biocatalysis products P, but not the corresponding substrates S.
  • the host strain was furthermore modified in such a manner that when the desired product P was recognized, this activated specific intracellular reporter expression systems or selection systems that enabled the cells to survive and grow under specific selective conditions. Cells which did not produce the desired product(s) P did not activate these reporter expression systems or selection systems. Such cells did not survive, and did not form colonies on selective plates (antibiotic comprising solid growth media). Thus, during growth on selective plates, only cells that produced the enzyme which in turn catalyzed the conversion of a substrate S to a desired product P were able to grow, and were hence selected.
  • the aspects as described herein can be used to detect a particular reaction product P by choosing a regulatory protein with the appropriate binding specificity.
  • a regulatory protein with the appropriate binding specificity.
  • XyIC benzaldehyde dehydrogenase
  • For the detection of benzoate or 2-hydroxybenzoate a previously described mutant of the transcriptional activator protein NahR from P. putida (Cebolla et al, 1997) was chosen.
  • This mutant recognizes both benzoic acids (the products), but not the corresponding aldehydes (the substrates), and activates transcription from its cognate salicylate promoter Psai.
  • the system reports the presence of an active biocatalyst on the basis of either a screenable or a selectable cellular phenotype.
  • the system easily selects biocatalyst containing cells present in the test culture at frequencies as low as 10' 6 .
  • the biocatalyst detector system described here can be modified to recognize a wide range of biocatalysis products.
  • NahR has the conserved domain architecture of a LysR type transcriptional regulator: a strongly conserved N- terminal domain with a HTH DNA binding motif and a C-terminal region required for multimerization are separated by a central region involved in effector recognition (Schell et al., 1990; Tropel and van der Meer, 2004). Mutagenesis directed at the effector binding region produced mutants with higher sensitivity, lower basal detector gene expression, stronger induction and the ability to recognize non-natural effectors while retaining the ability to bind to DNA and activate transcription. Most importantly, however, NahR is far from being an exception.
  • the conserved domain architecture the typical small molecule binding domains and strongly conserved DNA binding domains serve as markers to retrieve potential regulators from genomic sequence databases (Perez-Rueda et al., 2000; Anantharaman et al., 2001; Babu et al., 2003). Incorporation of newly identified regulator and promoter sequences into commercially available standardized detector plasmids can further reduce development time.
  • the present invention provides an in vi ⁇ o biocatalyst detection strategy based on product recognition by a bacterial regulatory protein coupled to expression of a selection gene such as tetA, which permits growth of active biocatalyst containing selection hosts against a large background of inactive recombinants.
  • a selection gene such as tetA
  • biocatalyst detector system described herein can easily be modified to recognize a wide range of biocatalysis products by replacing NahR and P sa i with other regulator/promoter pairs. Once this is done for a specific substrate-product pair, both screening (via lacZa or other easily detectable markers) and selection (with tetA or other antibiotic resistance genes) for relevant biocatalysts becomes possible.
  • the charm of the detection approach is that it requires only classical and very simple microbiological methods, such as culturing entire metagenome libraries (10 7 - 10 10 cells) in 1 — 100 ml liquid cultures and enriching for only those cells that survive antibiotics and presumably contain the biocatalysts of choice, thus enabling rapid selection of improved biocatalysts among shuffled or otherwise modified variants.
  • reporter or selector genes coding for fluorescent proteins (Cormack et al., 1996) or cell surface displayed binding proteins (Samuelson et al., 2002), producing chemosensor systems compatible with powerful and established analytical methods like fluorescence activated cell sorting (FACS) (Daugherty et al., 2000) and affinity chromatography (Patel et al., 2001; Ferenci and Lee, 1982).
  • FACS fluorescence activated cell sorting
  • each of the natural regulatory proteins can be modified by mutagenesis protocols (Cebolla et al., 1997; Ramos et al., 1990; Garmendia et al., 2001) or computational design (Looger et al., 2003; Hellinga, and Marvin 1998), to generate proteins with altered inducer or in this case, product specificities.
  • T4 DNA Ligase and Klenow DNA Polymerase were purchased from New England Biolabs Inc., Ipswich, MA, USA and Fermentas GmbH, St. Leon-Rot, Germany.
  • Taq DNA Polymerase was from Sigma-Aldrich Corp. St. Louis, MO, USA and Dynazyme DNA Polymerase from Finnzyme, Espoo, Finland.
  • AU oligos for PCR amplification were custom synthetized by Microsynth AG, Balgach, Switzerland.
  • the TOPO TA cloning Kit was obtained from Invitrogen, Breda, The Netherlands. All other chemicals were purchased either from Merck & Co, Whitehouse Station, NJ, USA, Fluka AG, Buchs SG, Switzerland or GERBU Biochemicals GmbH, Gaiberg, Germany.
  • Escherichia coli strain DHlOB was used for routine cloning, plasmid propagation and ⁇ -galaetosidase or growth assays. Bacteria were grown in Luria-Bertani (LB) medium and supplemented where required with 100 ⁇ g/ml ampicillin, 25 ⁇ g/ml kanamycin, 30 ⁇ g/ml chloramphenicol and 15-25 ⁇ g/ml tetracycline. PCRs were carried out with Dynazyme DNA Polymerase using a Perkin-Elmer GeneAmp PCR system 9600
  • Plasmid pVSF2 was constructed from pMG209 and pCKOl.
  • Plasmid pMG209 is a dual-promoter plasmid with a salicylate promoter (Ps ⁇ /) and a T7 RNA polymerase promoter (PT7). In addition, it contains the divergently transcribed nahR gene coding for the wild type transcriptional regulator NahR.
  • Plasmid pCKOl (Fernandez et al., 1995) is a low-copy cloning vector that confers chloramphenicol resistance.
  • the mutation N169D and a Pstl restriction site were introduced into the nahR gene of pMG209 with the Quick Change mutagenesis Kit (Stratagene, La Jolla, CA), using the forward and reverse primers PnahRmtl (5'-gccggctgctgcaggatcactacgtgtgcc-3', mutagenized bases bold, Pstl site underlined) and PnahRmt2 (5'-ggcacacgtagtgatcctgcagcagccggc-3'), respectively.
  • the PCR fragment was cloned into the blue/white selection vector pCR2.1-TOPO and sequenced with primers -40fw (5'-agggttttcccagtcacgacgtt- 3') and -40rv (5'-gagcggataacaatttcacagg-3').
  • primers -40fw 5'-agggttttcccagtcacgacgtt- 3'
  • -40rv 5'-gagcggataacaatttcacagg-3'
  • Plasmid pCKOl was linearized with Ndel, blunted with Klenow DNA polymerase and digested with BamHl to yield a 3097 bp fragment with one blunted and one overhanging end containing the chloramphenicol resistance gene, the origin of replication and genes required for plasmid replication. Ligation of these two fragments yielded the low-copy plasmid pVSF2.
  • lacZa was generated on template pCKOl with primers PlacZfw (5'-cgccatatgaccatgattacgaattgcggc-3') and PlacZrv (5'- cctcgagttagcgccattcgccattcagg-3').
  • PlacZfw 5'-cgccatatgaccatgattacgaattgcggc-3'
  • PlacZrv 5'- cctcgagttagcgccattcgccattcagg-3'.
  • the 267 bp fragment was cloned into pCR2.1-TOPO and sequenced with primers — 40fw and -40rv.
  • the fragment was excised from pCR2.1- TOPO with Ndel/Xhol and ligated into pVSF2.
  • tetA was amplified from pUC26 with primers PtetNde (5'-ggaattccatatgaaatctaacaatgcgctcatcgtcatcc-3') and PtetXho (5'- ccgctcgagtcaggtcgaggtggcccggctc-3 ! ).
  • PtetNde 5'-ggaattccatatgaaatctaacaatgcgctcatcgtcatcc-3'
  • PtetXho 5'- ccgctcgagtcaggtcgaggtggcccggctc-3 ! .
  • the 1210 bp fragment was cloned into pCR2.1- TOPO and sequenced with primers — 40fw and -40rv.
  • the fragment was excised from pCR2.1-TOPO with Ndel/Xhol and ligated into
  • Plasmid pComlO is a high-copy expression vector based on the alkane-responsive promoter PaikB and its positive regulator AIkS, that is compatible with the low-copy reporter plasmids. Expression of XyIC from the AIk promoter is regulated by the transcriptional activator AIkS and can be induced by decane.
  • pComlO- XyIC the xylC gene coding for benzaldehyde dehydrogenase XyIC from Pseudomonas putida was amplified from pCK04AXylR with primers PXylCfw (5'- cgccatatgcgggaaacaaaagagcagcc-3') and PXylCrv (5'- caagctttcaaaatgggtaattagctggcttctca-3').
  • the resulting 1477 bp fragment was cloned into pCR2.1-TOPO, sequenced with primers -40fw and -40rv, excised from pCR2.1- TOPO with Ndel/Hindlll and ligated into pComlO.
  • DHlOB-p VSF-tet r /pComlO-XylC was cured of pComlO-XylC by three successive rounds of growth in liquid LB medium containing only chloramphenicol (30 ⁇ g/ml) and 0.05 % dicyclopropylketone (DCPK). Since plasmid pComlO-XylC confers kanamycin resistance, kanamycin was omitted from the medium. Addition of DCPK induced expression of xylC and resulted in selection pressure against cells containing pComlO-XylC.
  • DCPK dicyclopropylketone
  • Plasmids were isolated from cells that were able to grow on plates containing chloramphenicol but had lost the ability to grow in the presence of kanamycin. Restriction analysis of plasmids confirmed that cells were cured of pComlO-XylC and retained pVSF2-tet r .
  • E. coli DHlOB cells harbouring reporter plasmid pVSF2-lacZ were streaked on the plates from a liquid culture that had been grown at 30 0 C to an ODeoo of 0.1. Cells were grown for 36 h at 30 0 C followed by incubation at 4 0 C for 24 h after which blue colony color formation was evaluated visually.
  • E. coli DHlOB cells harbouring reporter plasmid pVSF2-lacZ were streaked on the plates from a liquid culture that had been grown at 30 0 C to an ODeoo of 0.1. Cells were grown for 36 h at 30 0 C followed by incubation at 4 0 C for 24 h after which blue colony color formation was evaluated visually.
  • coli DHlOB cells harbouring the reporter plasmid pVSF2-lacZ together with either the catalyst containing plasmid pComlO-XylC or, as a control, the empty pComlO vector, grown in a liquid culture at 30 0 C to an OD600 of 0.1, were similarly streaked on identical X-Gal/chloramphenicol plates supplemented with kanamycin (25 ⁇ g/ml) and various concentrations of either benzaldehyde or 2-hydroxybenzaldehyde. Cells were plated and grown as above, under decane vapor, followed by incubation at 4 0 C and testing for blue colony color as above.
  • E. coli DHlOB cells harbouring the reporter plasmid pVSF2-tet r , grown in liquid culture at 30 0 C to an OD ⁇ oo of 0.1, were spread onto nonselective LB/agar plates containing only chloramphenicol (30 ⁇ g/ml) and onto selective plates containing chloramphenicol (30 ⁇ g/ml), tetracycline (22.5 ⁇ g/ml) and varying concentrations of benzoate. Identical non-selective and selective plates were supplemented with varying concentrations of 2-hydroxybenzoate, except that the tetracycline concentration was 25 ⁇ g/ml.
  • E. coli DHlOB cells harbouring the reporter plasmid pVSF2-tet r and either the catalyst containing plasmid pComlO-XylC or, as a control, the empty pComlO vector, were similarly grown and spread onto non-selective LB/agar plates containing only chloramphenicol (30 ⁇ g/ml) and kanamycin (25 ⁇ g/ml) and onto selective plates containing chloramphenicol (30 ⁇ g/ml), kanamycin (25 ⁇ g/ml), tetracycline (22.5 ⁇ g/ml) and varying concentrations of benzaldehyde.
  • Strain DHlOB harbouring pVSF2-tet r and either pComlO or pComlO-XylC was grown in liquid culture to an OD600 of 0.1.
  • the two cultures were diluted and mixed in ratios of 10 4 :l, 10 5 :l and 10 6 :l, keeping the amount of cells containing pComlO-XylC constant at 10 2 while increasing the amount of cells containing pComlO from 10 6 to 10 7 to 10 8 .
  • the cells were spread onto selective LB/agar plates containing chloramphenicol (30 ⁇ g/ml), kanamycin (25 ⁇ g/ml), tetracycline (25 ⁇ g/ml) and either benzaldehyde (200 ⁇ M) or 2-hydroxybenzaldehyde (5 ⁇ M) and incubated for 36 h at 30 0 C during which time the cells were exposed to decane vapor.
  • the plate assay was conducted in triplicate and per ratio and substrate the plasmids of 10 colonies were isolated and analyzed by restriction digest with NcM and Hind ⁇ ll for the presence of the xylC gene. In addition, the 60 colonies were subjected to a second assay.
  • the cells were re-streaked onto selective LB/agar plates containing chloramphenicol (30 ⁇ g/ml), kanamycin (25 ⁇ g/ml), tetracycline (25 ⁇ g/ml) and either no substrate, 200 ⁇ M benzaldehyde or 5 ⁇ M 2-hydroxybenzaldehyde. Plates were incubated for 36 h at 30 0 C under decane vapor.
  • Plasmid pVSF2-lacZ carries a gene coding for the ⁇ - fragment of ⁇ -galactosidase
  • plasmid pVSF2-tet r carries the tetracycline resistance gene tetA.
  • Both plasmids carry a constitutively expressed gene coding for a mutated form of the regulatory protein NahR (figure 2). In contrast to wild type NahR, this mutant recognizes benzoate as an inducer and has an increased affinity for the natural inducer 2-hydroxybenzoate.
  • E. coli hosts that carry either plasmid should express the reporter or selector genes, producing a screenable (lacZ ⁇ ) or a selectable (tetA) phenotype when grown in the presence of benzoate and 2- hydroxybenzoate.
  • Blue colonies of DHlOB-pVSF2-lacZ were detected at benzoate concentrations higher than 100 ⁇ M and 2-hydroxybenzoate concentrations higher than 10 ⁇ M,with a saturating concentration around 500 ⁇ M or 100 ⁇ M 2-hydroxybenzoate, respectively. Blue colonies were not formed in the absence of inducers.
  • Benzaldehyde dehydrogenase (XyIC) into the strain.
  • Strain DHlOB-pVSF2-lacZ was transformed with pComlO-XylC, streaked on plates containing chloramphenicol, kanamycin, X-GaI and varying concentrations of benzaldehyde or 2-hydroxybenzaldehyde, and grown exposed to decane vapor to induce XyIC.
  • Strain DH10B-pVSF2-lacZ, carrying an empty pComlO vector served as control.
  • Tables 4 and 5 show that on plates containing the XyIC substrates benzaldehyde (Table 4) or 2-hydroxybenzaldehyde (Table 5), the biocat - reporter strain (DHlOB-pVSF2-lacZ/pComlO-XylC) formed blue colonies at benzaldehyde concentrations above 50 ⁇ M and 2-hydroxybenzaldehyde concentrations above 25 ⁇ M. In the absence of substrate, the colonies remained white. The control strain (DHlOB- pVSF2-lacZ/pComlO) showed no blue colonies on addition of benzaldehydes.
  • the fast growing DH10B-pVSF2-tet r /pComl0-XylC strain was then cured of plasmid pComlO-XylC.
  • the resulting DH10B-pVSF2-tet r strain was able to grow on non-selective plates without inducers, whereas growth on selective plates required addition of benzoate or 2-hydroxybenzoate.
  • Plasmid pComlO-XylC was re-introduced into DH10B-pVSF2-tet r to produce the desired biocat - selector strain DH10B-pVSF2-tet r / pComlO-XylC.
  • This strain grew on tetracycline containing selective plates only after addition of benzaldehyde or 2-hydroxybenzaldehyde.
  • the effect of aldehydes on growth also showed a dose dependence (figure 4). On plates containing more than 100 ⁇ M benzaldehyde or 2 ⁇ M 2-hydroxybenzaldehyde, all plated cells grew.
  • the aldehyde substrates were about 65 times more effective than the acid products in triggering the antibiotic resistance response and the 2-hydroxy substituted compounds were about 15 — 20 fold more effective than the parent compounds in triggering a response.
  • DHlOB cells containing the active enzyme XyIC were mixed with cells lacking the enzyme in ratios of 1: 10 4 , l:10 5 and l:10 6 and plated on selective and non-selective plates.
  • the number of colonies that appeared on selective plates containing benzaldehyde or 2-hydroxybenzaldehyde corresponded to the number of enzyme containing cells plated. For each ratio and substrate, 10 colonies were tested for pComlO-XylC.
  • biocatalyst containing cells in a mixture of a large number of cells that do not contain biocatalyst was illustrated for the enzyme benzaldehyde dehydrogenase that converts benzaldehyde and related compounds (e.g., 2- hydroxybenzaldehyde) to benzoate or the corresponding related acids (e.g., 2- hydroxybenzoate).
  • benzaldehyde dehydrogenase that converts benzaldehyde and related compounds (e.g., 2- hydroxybenzaldehyde) to benzoate or the corresponding related acids (e.g., 2- hydroxybenzoate).
  • benzaldehyde or related aldehydes were converted to products (benzoate or related acids), these products could bind to a receptor protein encoded by a nahR * variant that has been introduced into the host cell; the receptor protein is a transcriptional activator which can activate one or more of several proteins or enzymes that together produce a detectable signal (e.g., color) or permit growth in the presence of an antibiotic.
  • a detectable signal e.g., color
  • benzoate production via the transcriptional activator protein NahR * coupling product recognition to expression of lacZa, a color indicator, or tetA, an antibiotic resistance gene.
  • Colonies developed when test cells were plated on selective media containing benzoic or 2-hydroxybenzoic acid. These XyIC products bound the NaKR regulator, and induced tetA expression with consequent tetracycline antiporter activity, enabling cell growth in the presence of tetracycline. Colonies were formed with minimum concentrations of 10 ⁇ M 2-hydroxybenzoate or 100 ⁇ M benzoate. Cells plated on selective media containing the substrates benzaldehyde or 2- hydroxybenzaldehyde formed colonies only when they expressed xylC and produced the corresponding products.
  • Intracellular and extracellular benzaldehyde and benzoate concentrations equilibrate within a few seconds and one minute, respectively.
  • Substrate is oxidized to benzoate by XyIC, and accumulates to a steady state intracellular concentration dictated by the relative synthesis and efflux rates.
  • Passive efflux increases as the intracellular benzoate concentration increases until the benzoate efflux rate equals the benzoate synthesis rate, resulting in a steady state benzoate concentration.
  • the benzoate efflux rate can be expected to equal the benzoate synthesis rate when a steady state benzoate concentration of around 400 ⁇ M is reached, the concentration needed for half maximal colony development when added extracellularly (Figure 3). Given its relatively rapid equilibration under these conditions, benzoate is expected to also be present at this concentration intracellularly.
  • the substrate concentration was chosen to enable selection of cells that contain biocatalyst activity. These conditions were established easily and quickly by plating a large population of biocatalyst containing cells with several substate and antibiotic concentrations.
  • the effect of the substrate concentration is illustrated by results obtained with the 2-hydroxy substituted substrate and product set. About 15 - 20 times less 2- hydroxybenzoate than benzoate was needed to trigger tetracycline resistance and enable growth of test cells. When substrate rather than product was added to cells that contained XyIC, colonies developed to half maximal diameter at only 0.3 ⁇ M 2- hydroxybenzaldehyde, compared to the 20 ⁇ M 2-hydroxybenzoate needed for similar colony development. Thus, as was the case with the unsubstituted benzaldehyde and benzoate, the substrate was ca. 65 times more efficient than the product in triggering tetracycline resistance.
  • the 2-hydroxy substituted substrate evidently crossed the cytoplasmic membrane more easily than did the corresponding product.
  • the ability to fine-tune the stringency of a selection through altering basic parameters is important if one wishes to test a library for variants that show a 2-fold or smaller improvement in catalytic activity. If two enzymes with small differences in activity are tested under conditions where both signals (product concentrations) saturate the chemosensor protein, it is simplest to lower the concentration of the extracellularly added substrate, possibly in combination with a change of the tetracycline concentration, as illustrated by the 2-hydroxybenzaldehyde experiments,. More complex, but useful in biocatalyst optimization experiments, a reduction of catalyst expression levels can reduce the initial biocatalyst activity to a range that allows comparisons between closely related variants.
  • the dynamic range and resolution of the test system Colony size is a function of the growth rate ⁇ . This depends on the maximum growth rate ⁇ ma ⁇ and the steady state intracellular tetracycline concentration, which is a function of the medium tetracycline concentration, the rate of tetracycline influx, and the antiporter activity elicited by product binding to NahB, in our experiments.
  • Tetracycline binds to the ribosomal A site with a Ka that has been variously reported as 5 ⁇ M (Burdettt, 1996, Connell et al., 2003), and up to 30 ⁇ M.
  • Colony diameter is a sensitive measure of growth rate differentials. Based on typical E. coli dimensions of 1 ⁇ m 3 per wet cell, 30% space between cells in the colony, and assuming no lag in cell division after plating, colonies with growth rates below 0.25 h 1 contain at most 8,200 cells after 36 hours, and have diameters smaller than 0.05 mm. Such colonies are essentially invisible.
  • the growth rates needed to produce the colonies seen in Figure 5, which develop diameters of 0.2 to 1.0 mm in 36 hours, range from ⁇ 0.39 Ir 1 to 0.50 h 1 , or about 80 — 100% of ⁇ max.
  • a 1.29-fold range of growth rates resulting in a 5-fold range of colony diameters in our plating experiments reports on a range of intracellular tetracycline concentrations of ca. 5 — 50% of Kd.
  • Burdett, V. Tet(M)-promoted release of tetracycline from ribosomes is GTP dependent. J. Bacteriol. 178 (11), 3246-51 (1996). Burton, S. G., Cowan, D. A. & Woodley, J. M. The search for the ideal biocatalyst.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

L'invention porte sur un procédé de détection parmi une population de biocatalyseurs d'un biocatalyseur capable de catalyser une réaction de conversion chimique d'un substrat en un produit. Ledit procédé comporte les étapes suivantes: (a) trouver une cellule hôte comprenant: (i) au moins un système d'expression inductible par le produit comprenant un acide nucléique codant pour au moins un gène détecteur fonctionnellement lié à un élément régulateur, l'expression dudit gène détecteur étant inductible par ledit produit, et (ii) au moins un système d'expression de biocatalyseur codant pour au moins un biocatalyseur candidat sélectionné dans ladite population de biocatalyseurs candidats; (b) mettre en contact ladite cellule hôte avec ledit substrat dans des conditions où ledit substrat peut entrer en contact avec ledit biocatalyseur candidat qui est converti dans ledit produit au cas où il puisse catalyser ladite réaction; et (c) détecter ladite cellule hôte comme étant capable de catalyser ladite réaction chimique de conversion sur la base de l'expression dudit gène détecteur.
PCT/NL2006/000646 2005-12-21 2006-12-20 Selection de biocatalyseurs de synthese chimique WO2007073163A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US12/158,335 US20090227470A1 (en) 2005-12-21 2006-12-20 Selection of biocatalysts for chemical synthesis

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US75264305P 2005-12-21 2005-12-21
EP05077951A EP1801212A1 (fr) 2005-12-21 2005-12-21 Sélection de biocatalyseurs pour la synthèse chimique
US60/752,643 2005-12-21
EP05077951.1 2005-12-21

Publications (1)

Publication Number Publication Date
WO2007073163A1 true WO2007073163A1 (fr) 2007-06-28

Family

ID=36168406

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/NL2006/000646 WO2007073163A1 (fr) 2005-12-21 2006-12-20 Selection de biocatalyseurs de synthese chimique

Country Status (3)

Country Link
US (1) US20090227470A1 (fr)
EP (1) EP1801212A1 (fr)
WO (1) WO2007073163A1 (fr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9040240B2 (en) 2011-02-25 2015-05-26 Universite De Lorraine Arsenic assay using ELISA
WO2016166303A1 (fr) * 2015-04-16 2016-10-20 Wageningen Universiteit Criblage commandé par riborégulateur et sélection des biocatalyseurs souhaités
WO2020089235A1 (fr) * 2018-10-29 2020-05-07 ETH Zürich Dosage pour le criblage de cellules et de microbes recombinants

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101918595A (zh) 2007-11-27 2010-12-15 人类遗传标记控股有限公司 用于扩增和复制亚硫酸氢盐修饰的核酸的酶
GB201309132D0 (en) * 2013-05-21 2013-07-03 Biosyntia Aps Regulatable gene expression
WO2017155945A1 (fr) * 2016-03-09 2017-09-14 President And Fellows Of Harvard College Procédés et systèmes de découverte et d'optimisation d'enzyme acellulaire
CN114807204B (zh) * 2022-04-12 2023-08-15 湖北大学 一种重组载体质粒、水杨酸生物传感器及构建方法和应用

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992006186A1 (fr) * 1990-09-28 1992-04-16 Amgen Inc. Cartouches de clonage et vecteurs d'expression dans des bacteries gram negatif
WO1994016332A1 (fr) * 1993-01-13 1994-07-21 Yeda Research And Development Co. Ltd. Procede de criblage de polypeptides et de proteines non enzymatiques catalytiques
WO1994024314A1 (fr) * 1993-04-19 1994-10-27 Kauffman Stuart A Procede aleatoire de production de nouveaux composes chimiques
WO1999002671A1 (fr) * 1997-07-07 1999-01-21 Medical Research Council Procede de selection in vitro
WO2000009682A1 (fr) * 1998-08-12 2000-02-24 Maxygen, Inc. Rearrangement d'adn de genes de monoxygenase en vue de la production de produits chimiques industriels
WO2000078976A1 (fr) * 1999-06-22 2000-12-28 Consejo Superior De Investigaciones Cientificas Expression regulee de genes clones a l'aide d'un circuit genetique en cascade

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6368793B1 (en) * 1998-10-14 2002-04-09 Microgenomics, Inc. Metabolic selection methods

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992006186A1 (fr) * 1990-09-28 1992-04-16 Amgen Inc. Cartouches de clonage et vecteurs d'expression dans des bacteries gram negatif
WO1994016332A1 (fr) * 1993-01-13 1994-07-21 Yeda Research And Development Co. Ltd. Procede de criblage de polypeptides et de proteines non enzymatiques catalytiques
WO1994024314A1 (fr) * 1993-04-19 1994-10-27 Kauffman Stuart A Procede aleatoire de production de nouveaux composes chimiques
WO1999002671A1 (fr) * 1997-07-07 1999-01-21 Medical Research Council Procede de selection in vitro
WO2000009682A1 (fr) * 1998-08-12 2000-02-24 Maxygen, Inc. Rearrangement d'adn de genes de monoxygenase en vue de la production de produits chimiques industriels
WO2000078976A1 (fr) * 1999-06-22 2000-12-28 Consejo Superior De Investigaciones Cientificas Expression regulee de genes clones a l'aide d'un circuit genetique en cascade

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
CEBOLLA A ET AL: "Effector specificity mutants of the transcriptional activator NahR of naphthalene degrading Pseudomonas define protein sites involved in binding of aromatic inducers.", THE JOURNAL OF BIOLOGICAL CHEMISTRY 14 FEB 1997, vol. 272, no. 7, 14 February 1997 (1997-02-14), pages 3986 - 3992, XP002421000, ISSN: 0021-9258 *
GAMPER M ET AL: "Probing the role of the C-terminus of Bacillus subtilis chorismate mutase by a novel random protein-termination strategy.", BIOCHEMISTRY 21 NOV 2000, vol. 39, no. 46, 21 November 2000 (2000-11-21), pages 14087 - 14094, XP002421001, ISSN: 0006-2960 *
KONARZYCKA-BESSLER MONIKA ET AL: "Select the best: novel biocatalysts for industrial applications.", TRENDS IN BIOTECHNOLOGY JUN 2006, vol. 24, no. 6, June 2006 (2006-06-01), pages 248 - 250, XP002420999, ISSN: 0167-7799 *
MOHN WILLIAM W ET AL: "Surveying biotransformations with à la carte genetic traps: translating dehydrochlorination of lindane (gamma-hexachlorocyclohex ane) into lacZ-based phenotypes.", ENVIRONMENTAL MICROBIOLOGY MAR 2006, vol. 8, no. 3, March 2006 (2006-03-01), pages 546 - 555, XP002420998, ISSN: 1462-2912 *
PARK H H ET AL: "NahR: effects of replacements at Asn 169 and Arg 248 on promoter binding and inducer recognition", ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, NEW YORK, US, US, vol. 434, no. 1, 1 February 2005 (2005-02-01), pages 67 - 74, XP004699352, ISSN: 0003-9861 *
VAN SINT FIET STEPHAN ET AL: "Selection of biocatalysts for chemical synthesis.", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 7 FEB 2006, vol. 103, no. 6, 30 January 2006 (2006-01-30), pages 1693 - 1698, XP002420997, ISSN: 0027-8424 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9040240B2 (en) 2011-02-25 2015-05-26 Universite De Lorraine Arsenic assay using ELISA
WO2016166303A1 (fr) * 2015-04-16 2016-10-20 Wageningen Universiteit Criblage commandé par riborégulateur et sélection des biocatalyseurs souhaités
WO2020089235A1 (fr) * 2018-10-29 2020-05-07 ETH Zürich Dosage pour le criblage de cellules et de microbes recombinants

Also Published As

Publication number Publication date
EP1801212A1 (fr) 2007-06-27
US20090227470A1 (en) 2009-09-10

Similar Documents

Publication Publication Date Title
Taylor et al. Investigating and engineering enzymes by genetic selection
Yim et al. Isolation of fully synthetic promoters for high‐level gene expression in Corynebacterium glutamicum
US20090227470A1 (en) Selection of biocatalysts for chemical synthesis
Auchtung et al. Biology of ICEBs1, an integrative and conjugative element in Bacillus subtilis
Videau et al. Assessment of Anabaena sp. strain PCC 7120 as a heterologous expression host for cyanobacterial natural products: Production of lyngbyatoxin A
Liang et al. Genome engineering of E. coli for improved styrene production
JP2001197895A (ja) 細胞工学および代謝工学のための方法および組成物
Chen et al. CRISPR/Cas9-facilitated engineering with growth-coupled and sensor-guided in vivo screening of enzyme variants for a more efficient chorismate pathway in E. coli
Sidiq et al. Alanine metabolism in Bacillus subtilis
Femmer et al. In vivo directed enzyme evolution in nanoliter reactors with antimetabolite selection
US20170226503A1 (en) Methods for Sequential Screening with Co-Culture Based Detection of Metagenomic Elements Conferring Heterologous Metabolite Secretion
Nilsson et al. Proteomic analysis of Rhizobium favelukesii LPU83 in response to acid stress
US20080206803A1 (en) Metabolic genes and related methods and compositions
Durante-Rodríguez et al. One-component systems that regulate the expression of degradation pathways for aromatic compounds
Jeschek et al. Periplasmic screening for artificial metalloenzymes
Martín‐Cabello et al. Characterization of a dszEABC operon providing fast growth on dibenzothiophene and construction of broad‐host‐range biodesulfurization catalysts
Sallam et al. New vector system for random, single-step integration of multiple copies of DNA into the Rhodococcus genome
Brixius‐Anderko et al. An indole‐deficient Escherichia coli strain improves screening of cytochromes P450 for biotechnological applications
Kugler et al. Development of a biosensor for crotonobetaine-CoA ligase screening based on the elucidation of Escherichia coli carnitine metabolism
US20200332303A1 (en) Regulatable gene expression
WO2020089235A1 (fr) Dosage pour le criblage de cellules et de microbes recombinants
Willetts et al. Multiple native flavin reductases in camphor-metabolizing Pseudomonas putida NCIMB 10007: functional interaction with two-component diketocamphane monooxygenase isoenzymes
KR101411716B1 (ko) 리보스위치를 이용한 라이신 고생산균 스크리닝 방법
EP0991778A1 (fr) Matieres de biocapteurs et procedes associes
CN113677795B (zh) 新型dahp合成酶

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 12158335

Country of ref document: US

122 Ep: pct application non-entry in european phase

Ref document number: 06835668

Country of ref document: EP

Kind code of ref document: A1